Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins
about
Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophagesPhorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules.Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3' sulfo-galactosyl ceramide-positive cell lineCell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages.A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.Human T-cell lymphotropic virus type 1 (HTLV-1)-induced syncytium formation mediated by vascular cell adhesion molecule-1: evidence for involvement of cell adhesion molecules in HTLV-1 biology.The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein.Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3Exceptional fusogenicity of Chinese hamster ovary cells with murine retroviruses suggests roles for cellular factor(s) and receptor clusters in the membrane fusion process.Infection of SK-N-MC cells, a CD4-negative neuroblastoma cell line, with primary human immunodeficiency virus type 1 isolates.
P2860
Q33807605-C35E2767-820E-4EAC-952A-4344EB8D71A5Q33944466-B3C994D1-F68B-4F7B-A54A-583CBF3FB609Q35847790-E2EB3DB0-FF4F-4748-8CD3-F87C2D618D00Q35851603-B26A363F-A39D-47A2-A0C9-EDFDCD835DF2Q35866377-01BCFA0F-7475-464A-8BE3-BE12FB99D9CFQ35868457-415BD127-CD5C-4F89-B2D2-68874FED8C81Q35876633-64AF8B40-81EF-4C4F-AAF8-AA9A51F57431Q36735905-FF1BDB47-8B30-42C2-AA39-77692ED183D7Q39594386-CB4C2CE4-9A00-4FE1-B482-6F7B7810E133Q39874520-E1FA1CB3-154A-45CC-A6A4-8A0D4E368C53Q39876649-0704EE32-D96E-44F0-8AA0-313BF0A7381E
P2860
Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Proteinase-resistant factors i ...... type 1 envelope glycoproteins
@ast
Proteinase-resistant factors i ...... type 1 envelope glycoproteins
@en
type
label
Proteinase-resistant factors i ...... type 1 envelope glycoproteins
@ast
Proteinase-resistant factors i ...... type 1 envelope glycoproteins
@en
prefLabel
Proteinase-resistant factors i ...... type 1 envelope glycoproteins
@ast
Proteinase-resistant factors i ...... type 1 envelope glycoproteins
@en
P2093
P2860
P1433
P1476
Proteinase-resistant factors i ...... type 1 envelope glycoproteins
@en
P2093
P2860
P304
P407
P577
1995-02-01T00:00:00Z